BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 79468)

  • 1. Novel drug metabolites produced by functionalization reactions: chemistry and toxicology.
    Testa B; Jenner P
    Drug Metab Rev; 1978; 7(2):325-69. PubMed ID: 79468
    [No Abstract]   [Full Text] [Related]  

  • 2. Xenobiotic metabolism by prostaglandin endoperoxide synthetase.
    Eling T; Boyd J; Reed G; Mason R; Sivarajah K
    Drug Metab Rev; 1983; 14(5):1023-53. PubMed ID: 6418501
    [No Abstract]   [Full Text] [Related]  

  • 3. DNA adducts of heterocyclic aromatic amines, arylazides and 4-nitroquinoline 1-oxide.
    Turesky RJ
    IARC Sci Publ; 1994; (125):217-28. PubMed ID: 7806314
    [No Abstract]   [Full Text] [Related]  

  • 4. Metabolic activation and drug toxicity.
    Nelson SD
    J Med Chem; 1982 Jul; 25(7):753-65. PubMed ID: 7050382
    [No Abstract]   [Full Text] [Related]  

  • 5. Metabolism of heterocyclic amines in cooked food.
    Alexander J; Wallin H; Holme JA; Brunborg G; Søderlund EJ; Becher G; Mikalsen A; Hongslo JK
    Prog Clin Biol Res; 1990; 340E():159-68. PubMed ID: 2203027
    [No Abstract]   [Full Text] [Related]  

  • 6. The reaction of amines with carbonyls: its significance in the nonenzymatic metabolism of xenobiotics.
    O'Donnell JP
    Drug Metab Rev; 1982; 13(1):123-59. PubMed ID: 6806054
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacologically active metabolites of drugs and other foreign compounds. Clinical, pharmacological, therapeutic and toxicological considerations.
    Drayer DE
    Drugs; 1982 Dec; 24(6):519-42. PubMed ID: 6759093
    [No Abstract]   [Full Text] [Related]  

  • 8. The concept of regioselectivity in drug metabolism.
    Testa B; Jenner B
    J Pharm Pharmacol; 1976 Oct; 28(10):731-44. PubMed ID: 62048
    [No Abstract]   [Full Text] [Related]  

  • 9. The metabolism of drugs and other foreign compounds in suspensions of isolated rat hepatocytes.
    McMahon RE
    Ann N Y Acad Sci; 1980; 349():46-56. PubMed ID: 6261639
    [No Abstract]   [Full Text] [Related]  

  • 10. Intermediates in drug metabolism reactions.
    Hucker HB
    Drug Metab Rev; 1973; 2(1):33-56. PubMed ID: 4590231
    [No Abstract]   [Full Text] [Related]  

  • 11. Aziridines and aziridinium ions in the practical synthesis of pharmaceutical intermediates--a perspective.
    Dahanukar VH; Zavialov IA
    Curr Opin Drug Discov Devel; 2002 Nov; 5(6):918-27. PubMed ID: 12478722
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Meat intake, metabolic genes and colorectal cancer.
    Le Marchand L
    IARC Sci Publ; 2002; 156():481-5. PubMed ID: 12484238
    [No Abstract]   [Full Text] [Related]  

  • 13. Metabolic capabilities of the human fetus: drug biotransformation.
    Juchau MR
    Addict Dis; 1975; 2(1-2):37-43. PubMed ID: 1163372
    [No Abstract]   [Full Text] [Related]  

  • 14. Pathways of drug metabolism in man.
    Drayer DE
    Med Clin North Am; 1974 Sep; 58(5):927-44. PubMed ID: 4609376
    [No Abstract]   [Full Text] [Related]  

  • 15. An approach measurement of the stoichiometric relationship between hepatic microsomal drug metabolism and the oxidation of reduced nicotinamide adenine dinucleotide phosphate.
    Stripp B; Zampaglione N; Hamrick M; Gillette JR
    Mol Pharmacol; 1972 Mar; 8(2):189-96. PubMed ID: 4402003
    [No Abstract]   [Full Text] [Related]  

  • 16. The characterization of an inhibitory complex formed with cytochrome P-450 and a metabolite of 1,1-disubstituted hydrazines.
    Hines RN; Prough RA
    J Pharmacol Exp Ther; 1980 Jul; 214(1):80-6. PubMed ID: 7391974
    [No Abstract]   [Full Text] [Related]  

  • 17. Refresher courses in pharmacology. 4. The biotransformation of drugs.
    Jenkins WL
    J S Afr Vet Med Assoc; 1971 Sep; 42(3):211-6. PubMed ID: 5161402
    [No Abstract]   [Full Text] [Related]  

  • 18. Drug metabolism: prospects for the future.
    Leibman KC
    Drug Metab Rev; 1979; 10(2):299-309. PubMed ID: 121804
    [No Abstract]   [Full Text] [Related]  

  • 19. Mechanisms of cytochrome P450 1A2-mediated formation of N-hydroxy arylamines and heterocyclic amines and their reaction with guanyl residues.
    Guengerich FP; Humphreys WG; Yun CH; Hammons GJ; Kadlubar FF; Seto Y; Okazaki O; Martin MV
    Princess Takamatsu Symp; 1995; 23():78-84. PubMed ID: 8844798
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Genetic differences in metabolism of polycyclic aromatic carcinogens and aromatic amines by mouse liver microsomes. Detection by DNA binding of metabolites and by mutagenicity in histidine-dependent Salmonella typhimurium in vitro.
    Levitt RC; Pelkonen O; Okey AB; Nebert DW
    J Natl Cancer Inst; 1979 Apr; 62(4):947-55. PubMed ID: 372661
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.